5-6633748-G-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001324323.2(SRD5A1):c.-550G>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000144 in 1,596,638 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001324323.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRD5A1 | ENST00000274192.7 | c.172G>C | p.Val58Leu | missense_variant | Exon 1 of 5 | 1 | NM_001047.4 | ENSP00000274192.5 | ||
SRD5A1 | ENST00000504286.1 | n.293G>C | non_coding_transcript_exon_variant | Exon 1 of 3 | 2 | ENSP00000518753.1 | ||||
SRD5A1 | ENST00000510531.5 | n.172G>C | non_coding_transcript_exon_variant | Exon 1 of 6 | 2 | ENSP00000425330.1 | ||||
SRD5A1 | ENST00000513117.1 | n.172G>C | non_coding_transcript_exon_variant | Exon 1 of 4 | 2 | ENSP00000421342.1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000229 AC: 5AN: 218228Hom.: 0 AF XY: 0.00000821 AC XY: 1AN XY: 121792
GnomAD4 exome AF: 0.00000692 AC: 10AN: 1444320Hom.: 0 Cov.: 35 AF XY: 0.00000556 AC XY: 4AN XY: 718916
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152318Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74472
ClinVar
Submissions by phenotype
not specified Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at